Fall 2016-Spring 2017 Schedule


Location: Simches Research Center, Room 3110
Time: 12:00–1:00 PM
Intended Audience: Internal MGH Faculty and Staff

The Massachusetts General Hospital Grand Rounds program has emerged as a premiere oncology conference in Boston. This program provides an opportunity for Mass General professional staff and fellows to learn from national and international leaders and innovators in cancer treatment and research.

Grand Rounds offers CME credit, and is structured as a 45 minute lecture followed by 15 minutes of discussion and interaction. Please see below to view the weekly topics and presenters.

October 2016

  • Alkylphosphocholine Analogs for Intraoperative Fluorescence, Cancer Imaging and Therapy

    October 6, 2016

    John S. Kuo, MD, PhD, FAANS, FACS
    Associate Professor of Neurological Surgery and Human Oncology (Tenure)
    Director, Comprehensive Brain Tumor Program
    Chair, CNS Tumors Group
    Carbone Cancer Center and Center for Stem Cell and Regenerative Medicine
    University of Wisconsin-Madison

  • Clinical Pathologic Conference: A 68-Year-Old Woman with Back Pain

    October 13, 2016

    Aditya Bardia, MD
    Massachusetts General Hospital Cancer Center

    Elena Brachtel, MD
    Massachusetts General Hospital

    Diane Doyle, NP
    Massachusetts General Hospital

    Valentina Nardi
    Massachusetts General Hospital

  • Targeting Quiescent Cancer Cells: New Insights & Opportunities

    October 20, 2016

    Sridhar Ramaswamy, MD
    Associate Professor of Medicine, Harvard Medical School
    Samana Cay MGH Research Scholar
    Director, Center for Cancer Systems Discovery
    Massachusetts General Hospital Cancer Center

  • Genetically-Modified T Cells to Treat Cancer: Past, Present, and Future

    October 27, 2016

    Marcela Maus, MD, PhD
    Director of Cellular Immunotherapy, Mass General Cancer Center
    Assistant Professor of Medicine, Harvard Medical School

November 2016

  • Synthetic Lethal Approaches to Cancer Therapy

    November 3, 2016

    Alan Ashworth, PhD, FRS
    President, UCSF Helen Diller Family Comprehensive Cancer Center
    Senior Vice President for Cancer Services, UCSF Health
    Professor of Medicine, Division of Hematology/Oncology, Department of Medicine

  • Myeloproliferative Neoplasms Update 2016

    November 17, 2016

    Ayalew Tefferi, MD
    Professor of Medicine and Hematology, Mayo Medical School
    Mayo Clinic

December 2016

  • Therapeutic Targeting of Head and Neck Cancer - Does HPV Make a Difference?

    December 8, 2016

    Robert Ferris, MD, PhD, FACS
    UPMC Endowed Professor and Vice-Chair
    Chief, Division of Head and Neck Surgery
    Associate Director for Translational Research Co-Leader, Cancer Immunology Program
    University of Pittsburgh Cancer Institute

  • Translating Research to Improve Cancer Patient Care

    December 15, 2016

    Johann de Bono
    Regius Professor of Cancer Research
    Professor of Experimental Cancer Medicine and Honorary Consultant in Medical Oncology
    Head of Division of Clinical Studies
    Director of Drug Development Unit and Head of Prostate Cancer Targeted Therapy Group
    The Institute of Cancer Research, University of London

January 2017

  • ASH Update

    January 5, 2017

    Andrew Brunner, MD
    Zachariah DeFilipp, MD
    Annemarie Fogerty, MD
    Ephraim Hochberg, MD
    Betsy O’Donnell, MD
    Mass General Cancer Center

  • New Developments in Lymphoma Therapy

    January 12, 2017

    John Leonard, MD
    Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
    Associate Dean for Clinical Research
    Vice Chairman, Joan and Sanford I. Weill Department of Medicine
    Chief, Lymphoma Service
    Associate Director, Sandra and Edward Meyer Cancer Center
    Attending Physician
    Weill Cornell Medicine | New York-Presbyterian

  • Molecular Imaging for Oncology: Application to Precision Medicine and Theranostics

    January 19, 2017

    Steven Larson, MD, FACNM, FACR
    Donna & Benjamin M. Rosen Chair
    Attending, Molecular Imaging and Therapy Service
    Department of Radiology
    Lab Head & Member, Molecular Pharmacology Program
    Sloan Kettering Institute
    Imaging and Radiation Science Program
    Comprehensive Cancer Center Grant, MSKCC
    Professor, Radiology Weill Cornell University Medical Center
    Center of Radioimmunotherapy and Theranostics at Ludwig Center Memorial Hospital

February 2017

  • Molecular Subtypes of Bladder Cancer and Subtype Specific Mouse Models

    February 2, 2017

    William Kim, MD
    Associate Professor of Medicine and Genetics
    Division of Hematology and Oncology
    Member, Lineberger Comprehensive Cancer Center
    UNC School of Medicine

  • Immunologic Checkpoint Blockade: Exploring Combinations and Mechanisms

    February 9, 2017

    Jedd Wolchok, MD, PhD
    Lloyd J. Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation
    Chief, Melanoma & Immunotherapeutics Service
    Associate Director, Ludwig Center for Cancer Immunotherapy
    Memorial Sloan-Kettering Cancer Center

  • From Gene Discovery to Cancer Surveillance: Lessons Learned from the Li-Fraumeni Syndrome

    February 16, 2017

    David Malkin, MD
    Director, Cancer Genetics Program
    Staff Oncologist, Division of Hematology/Oncology
    Senior Scientist, Genetics & Genome Biology Program
    The Hospital for Sick Children

March 2017

  • Understanding Glioma Cellular Heterogeneity as a Means to Rational Therapy

    March 2, 2017

    David Rowitch, MD
    Professor
    Howard Hughes Investigator
    UCSF School of Medicine

  • Have We Made Progress in Chronic GVHD?

    March 9, 2017

    Stephanie Lee, MD, PhD
    Member, Clinical Research Division
    Professor, University of Washington
    Fred Hutch

  • The Genetics of Myeloid Neoplasia: from Clonal Hematopoiesis to Acute Leukemia

    March 16, 2017

    Benjamin Ebert, MD, PhD
    Associate Professor, Medicine, Harvard Medical School
    Associate Physician, Hematology, Brigham And Women's Hospital

  • Clinical Pathologic Conference: A 45-Year-Old Man with Headache, Fever, and Lymphadenopathy

    March 23, 2017

    Ann LaCasce, MD
    Max Adelman, MD
    Efren Flores, MD
    Aliyah Sohani, MD
    Robert Goldstein, MD, PhD
    Massachusetts General Hospital Cancer Center

  • Enhancing the Immune Response with Ablative Radiation

    March 30, 2017

    Stephen Hahn, MD
    Professor and Gilbert H. Fletcher Memorial Distinguished Chair
    Division Head, Department Chair, Radiation Oncology
    The University of Texas MD Anderson Cancer Center

April 2017

  • FLT3 Inhibition in AML: A Long and Winding Road

    April 13, 2017

    Mark Levis, MD, PhD
    Program Leader, Hematologic Malignancies and Bone Marrow Transplant Program Sidney
    Kimmel Comprehensive Cancer Center
    Professor of Oncology, The Johns Hopkins University

  • Mechanisms of Immune Surveillance of Cancer

    April 27, 2017

    Robert Vonderheide, MD, DPhil
    Professor of Medicine
    Hanna Wise Professor in Cancer Research
    Associate Director for Translational Research, Abramson Cancer Center
    Vice Chief for Research, Hematology-Oncology Division, Department of Medicine
    University of Pennsylvania

May 2017

  • Surgical Research in Pancreatic Cancer

    May 4, 2017

    Steven Leach, MD
    Director, David M. Rubenstein Center for Pancreatic Cancer Research
    Memorial Sloan Kettering Cancer Center

  • Multiple Myeloma

    May 11, 2017

    Gareth Morgan, MD, PhD
    Director, Myeloma Institute
    University of Arkansas for Medical Sciences

  • Breast Cancer

    May 18, 2017

    Fabrice Andre, MD, PhD
    Research Director, Head of INSERM Unit U981
    INSERM (Institut National des Sciences et de la Recherche Médicale)
    Associate Professor, Department of Medical Oncology
    Institut Gustave Roussy
    Villejuif, France

  • Clinical Pathologic Conference

    May 25, 2017

    Speakers TBD